Literature DB >> 29033514

The Association between CHA2DS2-VASc Score and Mortality in Patients with Heart Failure with Reduced Ejection Fraction.

Orkun Temizer1, Burak Açar1, Çağrı Yayla1, Sefa Ünal1, Ahmet Göktuğ Ertem1, Esra Gücük İpek1, Uğur Canpolat1, Bihter Şentürk1, Hatice Selçuk1, Timur Selçuk1.   

Abstract

BACKGROUND: Heart failure (HF) is associated with significant mortality and morbidity. Therefore, identifying high-risk patients may optimize treatment for HF patients and reduce adverse events. The aim of this study was to assess the role of the CHA2DS2-VASc score to predict mortality in patients with reduced left ventricular ejection fraction (LVEF).
METHODS: A total of 106 patients with reduced LVEF were enrolled in this study. All patients completed a one-year follow-up, and a CHA2DS2-VASc score was calculated for each patient.
RESULTS: Twenty-one patients (19.8%) died during the 1-year follow-up. We found that baseline functional status, CHA2DS2-VASc score, brain natriuretic peptide, blood urea and hemoglobin levels were associated with mortality. In the multivariate analysis, CHA2DS2-VASc score and functional capacity were the only predictors of 1-year mortality.
CONCLUSIONS: Use of the CHA2DS2-VASc score appears to be feasible for risk stratification and mortality prediction in patients with reduced LVEF.

Entities:  

Keywords:  CHA2DS2-VASc score; Heart failure; Mortality

Year:  2017        PMID: 29033514      PMCID: PMC5534423          DOI: 10.6515/acs20170221a

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  20 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

2.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

3.  Role of the CHADS2 score in acute coronary syndromes: risk of subsequent death or stroke in patients with and without atrial fibrillation.

Authors:  Dritan Poçi; Marianne Hartford; Thomas Karlsson; Johan Herlitz; Nils Edvardsson; Kenneth Caidahl
Journal:  Chest       Date:  2011-10-20       Impact factor: 9.410

4.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

5.  TSOC-HFrEF Registry: A Registry of Hospitalized Patients with Decompensated Systolic Heart Failure: Description of Population and Management.

Authors:  Chun-Chieh Wang; Hung-Yu Chang; Wei-Hsian Yin; Yen-Wen Wu; Pao-Hsien Chu; Chih-Cheng Wu; Chih-Hsin Hsu; Ming-Shien Wen; Wen-Chol Voon; Wei-Shiang Lin; Jin-Long Huang; Shyh-Ming Chen; Ning-I Yang; Heng-Chia Chang; Kuan-Cheng Chang; Shih-Hsien Sung; Kou-Gi Shyu; Jiunn-Lee Lin; Guang-Yuan Mar; Kuei-Chuan Chan; Jen-Yuan Kuo; Ji-Hung Wang; Zhih-Cherng Chen; Wei-Kung Tseng; Wen-Jin Cherng
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

6.  CHA2DS2-VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention.

Authors:  Gokturk Ipek; Tolga Onuk; Mehmet B Karatas; Baris Gungor; Altug Osken; Muhammed Keskin; Ahmet Oz; Ozan Tanik; Mert Ilker Hayiroglu; Hale Yilmaz Yaka; Recep Ozturk; Osman Bolca
Journal:  Angiology       Date:  2015-12-17       Impact factor: 3.619

7.  Warfarin and aspirin in patients with heart failure and sinus rhythm.

Authors:  Shunichi Homma; John L P Thompson; Patrick M Pullicino; Bruce Levin; Ronald S Freudenberger; John R Teerlink; Susan E Ammon; Susan Graham; Ralph L Sacco; Douglas L Mann; J P Mohr; Barry M Massie; Arthur J Labovitz; Stefan D Anker; Dirk J Lok; Piotr Ponikowski; Conrado J Estol; Gregory Y H Lip; Marco R Di Tullio; Alexandra R Sanford; Vilma Mejia; Andre P Gabriel; Mirna L del Valle; Richard Buchsbaum
Journal:  N Engl J Med       Date:  2012-05-02       Impact factor: 91.245

8.  Increased Platelet-to-Lymphocyte Ratios and Low Relative Lymphocyte Counts Predict Appropriate Shocks in Heart Failure Patients with ICDs.

Authors:  Kevser Gülcihan Balci; Mustafa Mücahit Balci; Ugur Arslan; Burak Açar; Orhan Maden; Hatice Selcuk; Timur Selcuk
Journal:  Acta Cardiol Sin       Date:  2016-09       Impact factor: 2.672

9.  Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.

Authors:  Mark A Crandall; Benjamin D Horne; John D Day; Jeffrey L Anderson; Joseph B Muhlestein; Brian G Crandall; J Peter Weiss; Jeffrey S Osborne; Donald L Lappé; T Jared Bunch
Journal:  Pacing Clin Electrophysiol       Date:  2009-08       Impact factor: 1.976

10.  Atrial fibrillation ablation in systolic dysfunction: clinical and echocardiographic outcomes.

Authors:  Tasso Julio Lobo; Carlos Thiene Pachon; Jose Carlos Pachon; Enrique Indalecio Pachon; Maria Zelia Pachon; Juan Carlos Pachon; Tomas Guillermo Santillana; Juan Carlos Zerpa; Remy Nelson Albornoz; Adib Domingos Jatene
Journal:  Arq Bras Cardiol       Date:  2014-11-11       Impact factor: 2.000

View more
  1 in total

1.  Relationship Between CHA2DS2-VASc Score and Right Ventricular Dysfunction in Patients With Acute Pulmonary Thromboembolism.

Authors:  Murat Gök; Alparslan Kurtul; Murat Harman; Meryem Kara; Muhammed Süleymanoglu; Ender Ornek
Journal:  Clin Appl Thromb Hemost       Date:  2018-07-11       Impact factor: 2.389

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.